AG Scientific/奥斯特罗霉素A/O-2561/25毫克
商品编号:
O-2561-25mg
品牌:
agscientific
市场价:
¥23305.20
美元价:
13983.12
产品分类:
其他试剂
公司分类:
Other_reagents
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
*Please inquire the availability for this product. Ostreogrycin A (virginiamycin M1, streptogramin A) is the major component of the virginiamycin complex. In the 1950s this complex was independently discovered so many times that the literature became highly confusing. Ostreogrycin A is a macrocyclic lactone antibiotic that acts synergistically with the structurally unrelated cyclic depsipeptides, virginiamycin B (ostreogrycin B, streptogramin B) and virginiamycin S, to inhibit peptide elongation. This is achieved by blocking formation of a peptide bond between the growing peptide chain (peptidyl-tRNA) linked to the 50S ribosome and aminoacyl-tRNA. Ostreogrycin A is highly active against Gram positive bacteria, particularly MRSA.
Additional Information
Synonyms | Mikamycin A, Pristinamycin IIA, Stephylomycin M1, Streptogramin A, Syncothrecin A, Synergistin A1, Virginiamycin M1, Vernamycin A, 14752-2, E129A, PA 114A, 1745Z3A, 547C, Factor M |
---|---|
Product # | O-2561 |
CAS # | 21411-53-0 |
Formula | C28H35N3O7 |
MW | 525.6 |
Appearance | White solid |
Purity | >99% by HPLC |
Solubility | Soluble in water (partly), ethanol (4%), methanol (4%), DMF, and DMSO |
Melting Point | 165-167.2 °C |
Boiling Point | 825.2±65.0 °C at 760 mmHg |
Storage Temp | -20°C |
Therapeutic Area | Infectious Diseases |
Use | Ostreogrycin A has highly active against Gram positive bacteria |
Additional Information
MDL Number | MFCD00869411 |
---|---|
InChI | InChI=1S/C28H35N3O7/c1-17(2)26-19(4)9-10-24(34)29-11-5-7-18(3)13-20(32)14-21(33)15-25-30-22(16-37-25)27(35)31-12-6-8-23(31)28(36)38-26/h5,7-10,13,16-17,19-20,26,32H,6,11-12,14-15H2,1-4H3,(H,29,34)/b7-5+,10-9+,18-13+/t19-,20-,26-/m1/s1 |
SMILES | C[C@@H]1/C=C/C(=O)NC/C=C/C(=C/[C@H](CC(=O)Cc2nc(co2)C(=O)N3CCC=C3C(=O)O[C@@H]1C(C)C)O)/C |
品牌介绍
AG Scientific, Inc.成立于1997年,专注于创新生化制剂以及用于诊断测试开发的定制原材料,以推进临床前研究药物开发。产品涉及抗生素,生物洗涤剂,缓冲液,诊断,酶,医疗设备试剂,蛋白酶K,还原剂,RNase A等。